About this episode

Ganesh Sabat discusses the importance of quality in scaling MedTech companies and shares insights from his experience at Sahajanand Medical Technologies.

Summary “A company can become world class the day the quality team decides.” In this Let’s Talk Risk! conversation , host Naveen Agarwal engages with Ganesh Sabat, former former CEO of Sahajanand Medical Technologies (SMT) and now Founder & Managing Partner of MedArtha Capital about a simple but hard truth: global scale in MedTech is earned through quality execution, not marketing narratives. Ganesh walks through SMT’s transformation from an innovative startup into a globally recognized cardiovascular device company, then zooms out to India’s broader MedTech ambition. We unpack what’s missing (talent depth, shared learning, true design ownership), what’s emerging (incubation + device parks + incentives), and why quality leaders are the real “make-or-break” force behind India’s credibility on the world stage. Listen to the full 30-minute podcast or jump to a section of interest listed below. Chapters 00:00 Welcome and Introduction 02:09 SMT story: from “innovative startup” to global scale 04:54 The turning point: why Ganesh bet on quality as the growth lever 06:13 What investors demanded: proof, discipline, and scalable systems 08:39 India ecosystem reality: pharma-quality mindset…

People in this episode

Host: Naveen Agarwal

Guest: Ganesh Sabat

Topics covered

• MedTech
• quality management
• startup growth
• global scale
• innovation
• healthcare

Keywords

• MedTech
• quality execution
• startup
• cardiovascular devices
• India
• healthcare innovation

Mentioned in this episode

Organizations: Sahajanand Medical Technologies, MedArtha Capital

Places: India

More episodes of Let's Talk Risk! with Dr. Naveen Agarwal

• LTR 152: Omar Al Kalaa on Telesurgery and the Future of Remotely Controlled Medical Systems · April 24, 2026 · 36 min
• LTR 151: Sarai Pahla on Managing Supply Chain Disruption Risk in Life Sciences · April 17, 2026 · 26 min
• Case Study: How Patient Preference Data Rescued a High-Risk Device · April 10, 2026 · 21 min
• LTR 150: Jonathan Kendler on Rethinking Human Factors Engineering for AI/ML-Enabled Devices · April 3, 2026 · 29 min
• LTR 149: Lavanya Ramnath on Risk Analysis, IDE Strategy, and Patient-Centered Design · March 27, 2026 · 29 min
• LTR 148: Chris Daly on Companion Diagnostics, AI, and FDA’s Evolving Approach · March 20, 2026 · 29 min

Explore listener stats, chart rankings, contacts and more on the Let's Talk Risk! with Dr. Naveen Agarwal podcast page.